ConductScience.org, home

Paper20175270

NSAIDs in combination therapy for the treatment of chronic pseudophakic cystoid macular edema.

Warren KA and 2 others. Retina, 2010. Cited by 58 papers, by iCite.

Cite this record

ConductScience Library. NSAIDs in combination therapy for the treatment of chronic pseudophakic cystoid macular edema. Papers, record 20175270. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20175270

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
NSAIDs in combination therapy for the treatment of chronic pseudophakic cystoid macular edema.
PubMed
Journal
Retina
PubMed
Year
2010
PubMed
Publication types
Journal Article, Randomized Controlled Trial
PubMed
Citations, by iCite
58
iCite
Relative citation ratio, by iCite
2.75
iCite
Revised in PubMed
2019-09-07
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Warren KAKeith A
2Bahrani HHasan
3Fox JEJenni E

Source PubMed

Download CSV of authors

Topics30

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Angiogenesis InhibitorsMajor topic
Anti-Inflammatory Agents, Non-SteroidalMajor topic
Antibodies, MonoclonalMajor topic
GlucocorticoidsMajor topic
Macular EdemaMajor topic
PseudophakiaMajor topic
Triamcinolone AcetonideMajor topic
Aged
Aged, 80 and over
Antibodies, Monoclonal, Humanized
Benzeneacetamides
Benzophenones
Bevacizumab
Bromobenzenes
Diclofenac
Drug Therapy, Combination
Female
Fluorescein Angiography
Humans
Injections
Ketorolac
Male
Middle Aged
Phenylacetates
Retina
Single-Blind Method
Treatment Outcome
Vascular Endothelial Growth Factor A
Visual Acuity
Vitreous Body

Source PubMed

Download CSV of topics

Cited by31

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 58 citations.

PMIDTitleJournalYearIn PapersSource
41948371Imaging cystoid macular oedema secondary to branch retinal vein occlusion with spectral domain optical coherence tomography: A case report.SAGE Open Med Case Rep2026https://conductscience.org/library/papers/41948371PubMed
41557186Efficacy of anti-VEGF therapy for Irvine-Gass syndrome: a systematic review and meta-analysis.Graefes Arch Clin Exp Ophthalmol2026https://conductscience.org/library/papers/41557186PubMed
37723463Real-world treatment patterns and economic burden of post-cataract macular edema.BMC Ophthalmol2023https://conductscience.org/library/papers/37723463PubMed
37083870Topical bromfenac as adjunctive treatment with intravitreal ranibizumab for diabetic macular edema.Int Ophthalmol2023https://conductscience.org/library/papers/37083870PubMed
36520144Non-steroidal anti-inflammatory agents for treating cystoid macular edema following cataract surgery.Cochrane Database Syst Rev2022https://conductscience.org/library/papers/36520144PubMed
34708787Intravitreal anti-vascular endothelial growth factor with and without topical non-steroidal anti-inflammatory in centre-involving diabetic macular edema.Indian J Ophthalmol2021https://conductscience.org/library/papers/34708787PubMed
34640393Current Management Options in Irvine-Gass Syndrome: A Systemized Review.J Clin Med2021https://conductscience.org/library/papers/34640393PubMed
33492546Epiretinal membrane vitrectomy: outcomes with or without cataract surgery and a novel prognostic factor for cystoid macular edema.Graefes Arch Clin Exp Ophthalmol2021https://conductscience.org/library/papers/33492546PubMed
33192068Efficacy of Topical Nepafenac 0.3% in the Management of Postoperative Cystoid Macular Edema.Ther Clin Risk Manag2020https://conductscience.org/library/papers/33192068PubMed
32671307The Effect of Topical Bromfenac on Intraretinal and Subretinal Fluid in Neovascular Age-Related Macular Degeneration.J Curr Ophthalmol2020https://conductscience.org/library/papers/32671307PubMed
31664337Incidence of cystoid macular edema following routine cataract surgery using NSAIDs alone or with corticosteroids.Arq Bras Oftalmol2020https://conductscience.org/library/papers/31664337PubMed
31571815Macular edema associated with non-infectious uveitis: pathophysiology, etiology, prevalence, impact and management challenges.Clin Ophthalmol2019https://conductscience.org/library/papers/31571815PubMed
30809482Comparison of topical nepafenac 0.1% with intravitreal dexamethasone implant for the treatment of Irvine-Gass syndrome.Int J Ophthalmol2019https://conductscience.org/library/papers/30809482PubMed
30614750Novel Triamcinolone Acetonide-Loaded Liposomes Topical Formulation for the Treatment of Cystoid Macular Edema After Cataract Surgery: A Pilot Study.J Ocul Pharmacol Ther2019https://conductscience.org/library/papers/30614750PubMed
30581301Intravitreal diclofenac versus intravitreal bevacizumab in persistent diabetic macular edema: Anatomical and functional outcome.Saudi J Ophthalmol2018https://conductscience.org/library/papers/30581301PubMed
30046541Comparative study of the efficacy and safety of bromfenac, nepafenac and diclofenac sodium for the prevention of cystoid macular edema after phacoemulsification.Int J Ophthalmol2018https://conductscience.org/library/papers/30046541PubMed
28985220Combinatorial treatment with topical NSAIDs and anti-VEGF for age-related macular degeneration, a meta-analysis.PLoS One2017https://conductscience.org/library/papers/28985220PubMed
27822006Topical bromfenac for prevention and treatment of cystoid macular edema following cataract surgery: a review.Clin Ophthalmol2016https://conductscience.org/library/papers/27822006PubMed
27801522Prophylactic non-steroidal anti-inflammatory drugs for the prevention of macular oedema after cataract surgery.Cochrane Database Syst Rev2016https://conductscience.org/library/papers/27801522PubMed
27697257Cataract surgery and nonsteroidal antiinflammatory drugs.J Cataract Refract Surg2016https://conductscience.org/library/papers/27697257PubMed

See all 31 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/20175270

GET https://conductscience.org/api/papers/v1/20175270/cited_by?page=2